VICA Stock Overview
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rafina Innovations Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0015 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -90.00% |
| 3 Year Change | -99.92% |
| 5 Year Change | -99.93% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| VICA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | 0.7% |
| 1Y | -90.0% | -0.1% | 23.9% |
Return vs Industry: VICA underperformed the US Healthcare industry which returned -0.1% over the past year.
Return vs Market: VICA underperformed the US Market which returned 23.9% over the past year.
Price Volatility
| VICA volatility | |
|---|---|
| VICA Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VICA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VICA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | n/a | rafina-innovations.com |
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa.
Rafina Innovations Inc. Fundamentals Summary
| VICA fundamental statistics | |
|---|---|
| Market cap | US$13.90k |
| Earnings (TTM) | -US$5.78m |
| Revenue (TTM) | US$335.15k |
0.0x
P/S Ratio0.0x
P/E RatioIs VICA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VICA income statement (TTM) | |
|---|---|
| Revenue | US$335.15k |
| Cost of Revenue | US$92.35k |
| Gross Profit | US$242.80k |
| Other Expenses | US$6.02m |
| Earnings | -US$5.78m |
Last Reported Earnings
Mar 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VICA perform over the long term?
See historical performance and comparison